Table 1:
List of available samples per dataset, including number of samples, institution and description of sample type and source.
| Name of the dataset | Sample Count | Institution | Study Description |
|---|---|---|---|
| COVID-19-Adaptive | 160 | Adaptive | ImmuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs |
| COVID-19-BWNW | 50 | Bloodworks Northwest | Whole blood samples from convalescent patients collected at Bloodworks Northwest (Seattle, WA) |
| COVID-19-DLS | 433 | Discovery Life Sciences | Whole blood samples collected during routine patient care in acute and convalescent phases procured through Discovery Life Sciences (Huntsville, AL) |
| COVID-19-ISB | 157 | Institute for Systems Biology | Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease |
| COVID-19-NIH/NIAID | 357 | National Institute for Allergy and Infectious Diseases (NIAID) | Whole blood samples were collected in Brescia, Monza and Pavia (Italy) during active infection, and provided to the NIAID (Bethesda, MD) for DNA extraction |
| COVID-19-HUniv12Oct | 193 | Hospital Universitario 12 de Octubre | Whole blood samples were collected at the Hospital Univesitario 12 de Octubre (Madrid, Spain) during the active or convalescent phase |
| COVID-19-IRST/AUSL | 64 | Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) / AUSL-Romagna | Whole blood samples were collected by IRST/AUSL (Romagna, Italy) during active infection |